UTTER THERAPEUTICS Trademark

Trademark Overview


On Tuesday, May 14, 2024, a trademark application was filed for UTTER THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the UTTER THERAPEUTICS trademark a serial number of 98549544. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Wednesday, November 27, 2024. This trademark is owned by Utter Therapeutics Inc.. The UTTER THERAPEUTICS trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development in the pharmaceutical and biotechnology fields

General Information


Serial Number98549544
Word MarkUTTER THERAPEUTICS
Filing DateTuesday, May 14, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateWednesday, November 27, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesResearch and development in the pharmaceutical and biotechnology fields

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, May 14, 2024
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameUtter Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94107

Trademark Events


Event DateEvent Description
Tuesday, May 14, 2024NEW APPLICATION ENTERED
Thursday, November 14, 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, November 27, 2024NON-FINAL ACTION E-MAILED
Wednesday, November 27, 2024ASSIGNED TO EXAMINER
Wednesday, November 27, 2024NON-FINAL ACTION WRITTEN
Wednesday, November 27, 2024NOTIFICATION OF NON-FINAL ACTION E-MAILED